Trials / Completed
CompletedNCT03271333
Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.
Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma and Analysis of Associated Factors.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Diffuse infiltrating pneumonia (DIP) is a severe complication of systemic sclerosis and one of the leading cause of death in this condition. The main objective of this study is to prospectively describe the evolution of DIP overtime and to find prognosis factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | lung function tests | Patients hospitalized realise a Resting pulmonary function tests (PFT) which include the assessment of ventilatory capacity: spirometry (forced expiratory flows and mobilisable volumes) |
Timeline
- Start date
- 2018-04-10
- Primary completion
- 2024-12-31
- Completion
- 2025-12-11
- First posted
- 2017-09-05
- Last updated
- 2025-12-23
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03271333. Inclusion in this directory is not an endorsement.